INE013P01021
INE013P01021
ONESOURCE SPECL PHARMA L
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 167.57B EUR | 188.95B EUR | 168.87B EUR | 207.49B EUR |
Enterprise Value | 183.51B EUR | 188.95B EUR | 183.55B EUR | 207.49B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 19.35x | -- | -- | -- |
Price to Sales | 10.86x | 12.24x | 11.88x | 20.89x |
Price to Book | 2.88x | -- | 2.9x | -- |
EV/Revenue | 11.89x | 12.24x | 12.91x | 20.89x |
EV/EBITDA | 53.44x | 53.58x | 57.5x | 92.12x |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -- | -- | -- | -- |